AF
PACB icon

Allworth Financial’s Pacific Biosciences PACB Stock Holding History

Allworth Financial’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Sell
6,809
-1,119
-14% -$1.63K ﹤0.01% 3622
2026
Q1 		$10.5K Buy
7,928
+3,877
+96% +$6.94K ﹤0.01% 3466
2025
Q4 		$7.58K Sell
4,051
-481
-11% -$924 ﹤0.01% 3447
2025
Q3 		$5.8K Buy
4,532
+1,864
+70% +$2.52K ﹤0.01% 3467
2025
Q2 		$3.31K Sell
2,668
-2,176
-45% -$2.51K ﹤0.01% 3480
2025
Q1 		$5.52K Buy
4,844
+293
+6% +$449 ﹤0.01% 2705
2024
Q4 		$8.24K Buy
4,551
+2,947
+184% +$5.75K ﹤0.01% 2524
2024
Q3 		$2.73K Buy
1,604
+107
+7% +$176 ﹤0.01% 2830
2024
Q2 		$2.49K Buy
1,497
+1,418
+1,795% +$2.86K ﹤0.01% 2824
2024
Q1 		$297 Sell
79
-37
-32% -$217 ﹤0.01% 3399
2023
Q4 		$1.14K Sell
116
-205
-64% -$1.68K ﹤0.01% 2908
2023
Q3 		$2.68K Hold
321
– – ﹤0.01% 2401
2023
Q2 		$4.27K Hold
321
– – ﹤0.01% 2179
2023
Q1 		$3.72K Hold
321
– – ﹤0.01% 2151
2022
Q4 		$2.63K Buy
321
+43
+15% +$370 ﹤0.01% 2137
2022
Q3 		$2K Hold
278
– – ﹤0.01% 2198
2022
Q2 		$1K Buy
278
+36
+15% +$219 ﹤0.01% 2220
2022
Q1 		$2K Hold
242
– – ﹤0.01% 1812
2021
Q4 		$5K Hold
242
– – ﹤0.01% 1558
2021
Q3 		$6K Hold
242
– – ﹤0.01% 1485
2021
Q2 		$8K Hold
242
– – ﹤0.01% 1106
2021
Q1 		$8K Hold
242
– – ﹤0.01% 1039
2020
Q4 		$6K Hold
242
– – ﹤0.01% 949
2020
Q3 		$2K Hold
242
– – ﹤0.01% 1010
2020
Q2 		$1K Hold
242
– – ﹤0.01% 1120
2020
Q1 		$1K Hold
242
– – ﹤0.01% 1166
2019
Q4 		$1K Buy
+242
New +$1.23K ﹤0.01% 1000

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Allworth Financial's PACB Position: Q2 2026 in Review

Allworth Financial reduced its Pacific Biosciences (PACB) stake by 14% in Q2 2026, selling an estimated $1.63K and leaving 6,809 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3622.

Allworth Financial first reported a position in PACB in Q4 2019 and has held it in 27 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Allworth Financial held 6,809 shares of Pacific Biosciences worth $11.4K as of Q2 2026.
  • Allworth Financial sold 1,119 Pacific Biosciences shares in Q2 2026, an estimated $1.63K.
  • Pacific Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3622 holding.
  • Allworth Financial first reported a position in Pacific Biosciences in Q4 2019 and has held it in 27 quarters since.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.